Authors:
WIDIMSKY J
HULINSKY V
BALAZOVJECH I
LANSKA V
Citation: J. Widimsky et al., FLUVASTATIN VS FLUVASTATIN PLUS FENOFIBRATE IN CHD PATIENTS AND COMBINED HYPERLIPIDEMIA, Atherosclerosis, 134(1-2), 1997, pp. 63-63
Authors:
WIDIMSKY J
LANSKA V
JURAN F
LEISSER J
VANEK P
Citation: J. Widimsky et al., THE USE OF HYPOLIPIDEMIC DRUGS IN PATIENTS AFTER MYOCARDIAL REVASCULARIZATION IN THE CZECH-REPUBLIC, 1996, Atherosclerosis, 134(1-2), 1997, pp. 63-63
Authors:
WIDIMSKY J
HULINSKY V
BALAZOVJECH I
LANSKA V
Citation: J. Widimsky et al., CAN FLUVASTATIN BE EFFECTIVELY USED IN THE TREATMENT OF COMBINED HYPERLIPIDEMIA, Atherosclerosis, 134(1-2), 1997, pp. 125-125
Citation: I. Matl et al., A MULTICENTER STUDY OF CONSUPREN (CYCLOSPORINE) VERSUS CYCLOPHOSPHAMIDE IN CHRONIC GLOMERULONEPHRITIS, Transplantation proceedings, 28(6), 1996, pp. 3149-3151
Authors:
PELIKANOVA T
SMRCKOVA I
KRIZOVA J
STRIBRNA J
LANSKA V
Citation: T. Pelikanova et al., EFFECTS OF INSULIN AND LIPID EMULSION ON RENAL HEMODYNAMICS AND RENALSODIUM HANDLING IN IDDM, Diabetologia, 39(9), 1996, pp. 1074-1082
Citation: P. Lansky et V. Lanska, FIRST-PASSAGE-TIME PROBLEM FOR SIMULATED STOCHASTIC DIFFUSION-PROCESSES, Computers in biology and medicine, 24(2), 1994, pp. 91-101